Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - a review of the experimental evidence.
about
Thrombosis in ST-elevation myocardial infarction: Insights from thrombi retrieved by aspiration thrombectomyAnti-Inflammatory and Immunomodulatory Mechanism of Tanshinone IIA for AtherosclerosisUnderstanding the role of B cells in atherosclerosis: potential clinical implicationsThe Roles of CD137 Signaling in AtherosclerosisTear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating proceduresInflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: A qualitative relationship?Negative association between testosterone concentration and inflammatory markers in young men: a nested cross-sectional study.Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes.Biomarkers Related to Carotid Intima-Media Thickness and Plaques in Long-Term Survivors of Ischemic Stroke.Study protocol for the Maule Cohort (MAUCO) of chronic diseases, Chile 2014-2024Anti-inflammatory effects of a Chinese herbal medicine in atherosclerosis via estrogen receptor β mediating nitric oxide production and NF-κB suppression in endothelial cells.Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection.Immunoglobulin E (IgE) and ischemic heart disease. Which came first, the chicken or the egg?Regulator Versus Effector Paradigm: Interleukin-10 as Indicator of the Switching Response.RGS3 inhibits TGF-β1/Smad signalling in adventitial fibroblasts.Rho kinase inhibitor fasudil mitigates high-cholesterol diet-induced hypercholesterolemia and vascular damage.Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice.Ginsenoside F1 Ameliorates Endothelial Cell Inflammatory Injury and Prevents Atherosclerosis in Mice through A20-Mediated Suppression of NF-kB Signaling.Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.The relationship between complete blood count parameters and Fontaine's Stages in patients with peripheral arterial disease.Endothelial long non-coding RNAs regulated by oxidized LDL.
P2860
Q26746148-F5FBC933-F20A-4E04-AA32-1BEC3AF89759Q26825251-4AB92EDF-6A33-4886-B744-5F64E681B0A8Q26991813-257D8FEA-D371-4725-A6EB-E25657460F01Q28076613-E82A0D3C-82D0-4314-93E8-179D499106ACQ28393435-0094FF86-16FF-41E1-A294-453B10BE02D2Q33891946-FC77961D-929A-4A16-80E3-4840388B9678Q34700340-DCEDD552-86FF-4EC6-965B-FD4A848864D3Q35558887-F320D5B6-30EA-4F3C-B6DF-88BC1AD9738FQ35798763-191CACBD-D69B-46AD-8D72-8B85349DC4FAQ36550354-CC1A1840-07AE-49CC-8CB2-18ECE70DD48FQ36738086-13B8246C-0396-4AF1-8FB2-E4DFB68416C0Q37254899-DF28F56B-8CB4-4A5B-A545-D3B348890AE7Q37319195-B90CEE96-49E5-4792-93E1-0965E7EF950BQ38225228-DD2C22ED-AA9D-49AD-BCB0-9358946253A0Q38602859-B39FCEBA-FC50-4483-B966-D93DAAD0FA51Q40078040-CF567E74-B3B5-40DE-B86C-CC3433C64067Q46354788-842051B5-C106-49EB-B68E-0597FFF80C04Q47150117-A5DB6AC7-CE8D-4CFA-B43F-16487CFF5308Q47194713-42D44ADA-7DB0-4F2F-AD19-04A17AF8EC24Q49072554-F471C38F-3A55-4EC7-82BB-52D1A9400688Q50479261-300B4A27-CE1B-451E-B6AD-9B9910183046Q51094405-136AE9EE-19DC-4D03-8612-868A3F9F4884
P2860
Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis - a review of the experimental evidence.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Emerging biomarkers and interv ...... of the experimental evidence.
@en
type
label
Emerging biomarkers and interv ...... of the experimental evidence.
@en
prefLabel
Emerging biomarkers and interv ...... of the experimental evidence.
@en
P1433
P1476
Emerging biomarkers and interv ...... of the experimental evidence.
@en
P2093
Gunilla Nordin Fredrikson
Jan Nilsson
P356
10.1016/J.ATHEROSCLEROSIS.2012.10.074
P577
2012-11-06T00:00:00Z